Non-secretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib: a large UK cohort

BACKGROUND: Sorafenib is the current standard of care for patients with advanced or metastatic hepatocellular carcinoma. Currently no universally agreed model exists correlating the Neutrophil Lymphocyte ratio (NLR) and non-secretion of AFP with the survival of HCC patients treated with sorafenib. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Afshar, Mehran, Fletcher, Peter, Bardoli, Antonio D, Ma, Yuk Ting, Punia, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908300/
https://www.ncbi.nlm.nih.gov/pubmed/29682199
http://dx.doi.org/10.18632/oncotarget.24769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908300/
https://www.ncbi.nlm.nih.gov/pubmed/29682199
http://dx.doi.org/10.18632/oncotarget.24769

Ejemplares similares